Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00627263 · ClinicalTrials.gov registry record · NA
Stress Reduction to Reduce Risk for Arrhythmia in ICD Patients (The RISTA Study)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 314
- Enrollment target
NCT00627263 is a NA study that has completed, run by Yale University. The registered enrollment target is 314 participants.
The verdict
NCT00627263, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 314 participants
- Enrollment target
Study Summary
An implantable cardioverter defibrillator (ICD) is a small device that is implanted in the chest and uses electrical shocks to control arrhythmias, which are abnormal heart rhythms. Arrhythmias can be caused by many factors, including stress and anger. This study will evaluate the use of a stress reduction treatment (SRT) program aimed at reducing the occurrence of arrhythmias that require treatment with an ICD shock.
Interventions
- BEHAVIORAL Stress reduction treatment (SRT) program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00627263
The ClinicalTrials.gov registry entry for NCT00627263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stress reduction treatment (SRT) program is the first listed.
NCT00627263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00627263 about?
NCT00627263 is a clinical study titled "Stress Reduction to Reduce Risk for Arrhythmia in ICD Patients (The RISTA Study)". An implantable cardioverter defibrillator (ICD) is a small device that is implanted in the chest and uses electrical shocks to control arrhythmias, which are abnormal heart rhythms. Arrhythmias can be caused by many factors, including stress and anger. This study will evaluate the use of a stress re...
What is the current status of trial NCT00627263?
This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2008-01. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00627263?
The interventions under investigation include: Stress reduction treatment (SRT) program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00627263?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.